Iressa v BSC (Best Supportive Care) in First Line NSCLC
NCT00259064
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
216
Enrollment
INDUSTRY
Sponsor class
Conditions
NSCLC
Interventions
DRUG:
Gefitinib
OTHER:
Placebo
Sponsor
AstraZeneca